Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 4 (80%) |
| Double-patenting + other | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, DELPHINUS DOU YI | 1 | 50.0% | +0.0% |
| WEIDNER, ADAM M | 1 | 63.6% | +34.2% |
| WANG, CHANG YU | 1 | 33.2% | +53.3% |
| LI, RUIXIANG | 1 | 59.4% | +19.1% |
| ROONEY, NORA MAUREEN | 1 | 60.2% | +23.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18148448 | WNT RECEPTOR-SPECIFIC COMPOUND AND METHOD RELATING THERETO | WANG, CHANG YU | 77d |
| 18350589 | ANTI-LRP5/6 ANTIBODIES AND METHODS OF USE | WEIDNER, ADAM M | — |
| 17438303 | MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS | LI, RUIXIANG | — |
| 17257817 | MULTI-SPECIFIC WNT SURROGATE MOLECULES AND USES THEREOF | ROONEY, NORA MAUREEN | — |
| Art Unit | Apps |
|---|---|
| 1675 | 2 |
| 1674 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18597679 | TISSUE-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF | YU, DELPHINUS DOU YI | — | §112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18350589 | ANTI-LRP5/6 ANTIBODIES AND METHODS OF USE | WEIDNER, ADAM M | 1675 | §112 | Non-Final OA | — | Pending | Jul 11, 2023 |
| 18148448 | WNT RECEPTOR-SPECIFIC COMPOUND AND METHOD RELATING THERETO | WANG, CHANG YU | 1675 | §102§112DPOther | Non-Final OA | 77d | Pending | Dec 30, 2022 |
| 17438303 | MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS | LI, RUIXIANG | 1674 | §112 | Non-Final OA | — | Pending | Sep 10, 2021 |
| 17257817 | MULTI-SPECIFIC WNT SURROGATE MOLECULES AND USES THEREOF | ROONEY, NORA MAUREEN | 1641 | §112 | Non-Final OA | — | Pending | Jan 04, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial